In fact, although BRAF mutations are typically associated with a negative prognostic role especially in, lung cancer, melanoma, thyroid, and CRC, their positive predictive role has recently emerged in melanoma, lung cancer, thyroid carcinoma, CRC, and other cancers, such as glioma patients. This evidence concerns the gene BRAF and lung carcinoma.